NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $115,000 | +57.5% | 44,002 | 0.0% | 0.00% | – |
| Q4 2018 | $73,000 | -82.9% | 44,002 | -50.0% | 0.00% | – |
| Q3 2018 | $426,000 | +53.2% | 88,004 | +98.2% | 0.00% | – |
| Q2 2018 | $278,000 | -24.7% | 44,408 | 0.0% | 0.00% | – |
| Q1 2018 | $369,000 | -18.5% | 44,408 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $453,000 | +41.1% | 44,408 | +26.6% | 0.00% | – |
| Q3 2017 | $321,000 | +13.0% | 35,065 | -9.7% | 0.00% | – |
| Q2 2017 | $284,000 | +32.7% | 38,853 | +31.0% | 0.00% | – |
| Q1 2017 | $214,000 | +43.6% | 29,663 | +16.3% | 0.00% | – |
| Q4 2016 | $149,000 | +3.5% | 25,496 | +16.3% | 0.00% | – |
| Q3 2016 | $144,000 | -29.1% | 21,924 | 0.0% | 0.00% | – |
| Q2 2016 | $203,000 | +232.8% | 21,924 | +289.6% | 0.00% | – |
| Q1 2016 | $61,000 | -24.7% | 5,628 | 0.0% | 0.00% | – |
| Q4 2015 | $81,000 | -31.4% | 5,628 | 0.0% | 0.00% | – |
| Q3 2015 | $118,000 | – | 5,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 784,704 | $5,163,000 | 3.14% |
| WALL STREET ASSOCIATES | 149,343 | $983,000 | 0.34% |
| DAFNA Capital Management LLC | 38,873 | $256,000 | 0.18% |
| Perceptive Advisors | 330,593 | $2,175,000 | 0.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,508,000 | 0.07% |
| FALCON POINT CAPITAL, LLC | 69,135 | $408,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $333,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $526,000 | 0.01% |
| FRANKLIN RESOURCES INC | 1,314,700 | $8,650,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 215,000 | $1,415,000 | 0.00% |